Title:
ＩＧＦＢＰ２インヒビター
Document Type and Number:
Japanese Patent JP5816147
Kind Code:
B2
Abstract:
The present invention provides method for quickly and conveniently determining if a given treatment regimen of IGF1R inhibitor is sufficient, e.g., to saturate IGF1R receptors in the body of a subject. Several clinically relevant determinations may be made based on this point, including, for example, whether the dosage of the regimen is sufficient or should be increased.
Inventors:
Yang Wan
Application Number:
JP2012198693A
Publication Date:
November 18, 2015
Filing Date:
September 10, 2012
Export Citation:
Assignee:
Merck Sharp & Dohme Corp.
International Classes:
G01N33/53; A61K39/395; A61K45/00; A61K45/06; A61P5/14; A61P9/10; A61P17/06; A61P21/04; A61P25/00; A61P35/00; A61P35/02; A61P37/02; A61P43/00
Domestic Patent References:
| JP2003502383A | ||||
| JP2005504723A |
Attorney, Agent or Firm:
Yoshikazu Iwase
Makoto Ono
Kenkyo Kanayama
Mitsuaki Tsubokura
Kazuki Shigemori
Kenji Ando
Yasufumi Shiroyama
Makoto Ono
Kenkyo Kanayama
Mitsuaki Tsubokura
Kazuki Shigemori
Kenji Ando
Yasufumi Shiroyama